See also this year's filing and all EDGAR filings for this company.
PDF Report 0000744218_2017_Celldex_Therapeutics_Inc.pdf
Logs
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'OperatingIncomeLoss'} |
Graph
Absolute values for 0000744218, Celldex Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesNoncurrent | 82,704,000 |
| 1 | LiabilitiesCurrent | 35,223,000 |
| 2 | remainder_Liabilities | 0 |
| 3 | AssetsCurrent | 195,569,000 |
| 4 | AssetsNoncurrent | 2,134,000 |
| 5 | PropertyPlantAndEquipmentNet | 13,192,000 |
| 6 | Goodwill | 172,463,000 |
| 7 | remainder_Assets | 0 |
| 8 | GeneralAndAdministrativeExpense | 35,979,000 |
| 9 | ResearchAndDevelopmentExpense | 102,726,000 |
| 10 | remainder_Expenses | 997,000 |
| 11 | remainder_Revenues | 6,786,000 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 4,620,000 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 117,927,000 |
| 1 | Assets | 383,358,000 |
| 2 | Expenses | 139,702,000 |
| 3 | Revenues | 6,786,000 |
| 4 | StockholdersEquity | 265,431,000 |
| 5 | NetIncome | -132,916,000 |
| 6 | ComprehensiveNetIncome | -130,606,000 |
| 7 | BaseVar | 326,196,500 |
| 8 | EconomicCapitalRatio | 0.379 |
Edgar->Model Mapping
Feature Distribution
